Pandemic Flu Vaccine Approved For Children

03 December 2009

 
The Therapeutic Goods Administration (TGA) has today approved for registration the Australian-made Panvax H1N1 Vaccine Junior enabling children from 6 months to 9 years of age to be protected against the pandemic H1N1 influenza.

The registration by the TGA follows rigorous evaluation of clinical trial data by the regulator and review by the expert Australian Drug Evaluation Committee (ADEC). The TGA has stated that children under 10 years of age will require two doses of the vaccine administered at least 28 days apart, in line with the process for children’s seasonal flu vaccinations.

The vaccine has already been approved for use in older children and adults. Since it became available to the Australian public in September 2009 5.1 million doses have been distributed to immunisation providers, of which 4.2 million doses have gone to GPs.

PDF printable version of Pandemic Flu Vaccine Approved For Children

A link to Kids Vaccine Q&As